Nektar Therapeutics | NKTR - Current Assets


Nektar Therapeutics reported $266.27M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agios Pharmaceuticals USD 834.84M 107.21M Mar/2026
ALKERMES USD 1.36B 570.52M Mar/2026
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Amgen USD 31.48B 2.42B Mar/2026
Baxter International USD 6.85B 25M Mar/2026
BioCryst Pharmaceuticals USD 373.62M 30.72M Mar/2026
Biogen USD 9.19B 216.3M Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Cara Therapeutics USD 31.54M 6.9M Dec/2025
Cipla INR 241.47B 7.71B Mar/2026
Dr.Reddys Laboratories INR 301.79B 4.24B Mar/2026
Eisai JPY 761.64B 79.24B Mar/2026
Eli Lilly USD 54.84B 794M Mar/2026
Esperion Therapeutics USD 459.46M 3.11M Mar/2026
Exelixis USD 1.21B 234.65M Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Grifols EUR 5.96B 316.31M Dec/2025
Halozyme Therapeutics USD 1B 177.83M Mar/2026
Incyte USD 5.48B 460.36M Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
Ironwood Pharmaceuticals USD 332.29M 58.11M Mar/2026
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
MacroGenics USD 182.52M 37.42M Mar/2026
Merck USD 35.02B 8.5B Mar/2026
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Neurocrine Biosciences USD 2.44B 86.6M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Pfizer USD 42.82B 76M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sarepta Therapeutics USD 2.31B 228.06M Mar/2026
Takeda JPY 3.09T 25.94B Mar/2026
Teva Pharmaceutical Industries USD 13.71B 236M Mar/2026
Xencor USD 482.85M 116.97M Mar/2026